CN Stock MarketDetailed Quotes

300026 Tianjin Chase Sun Pharmaceutical

Watchlist
  • 3.70
  • -0.09-2.37%
Market Closed Jan 2 15:00 CST
11.12BMarket Cap67.27P/E (TTM)

Tianjin Chase Sun Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Tianjin Chase Sun Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 6.511B--
--2024/FY-- / 6.194B--
--2023/FY6.127B / 6.672B--
--2022/FY6.651B / 6.758B--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 6.511B--
--2024/FY-- / 6.194B--
--2023/FY6.127B / 6.672B--
--2022/FY6.651B / 6.758B--
--------

Unlock Free Earnings Estimates

Tianjin Chase Sun Pharmaceutical Earnings Reports

  • Hongri Pharmaceutical: Report for the third quarter of 2024

    Oct 24, 2024 12:00 ET

  • Hongri Pharmaceutical: 2024 Semi-Annual Report

    Aug 29, 2024 12:00 ET

  • Hongri Pharmaceutical: 2024 Semi-Annual Report Summary

    Aug 29, 2024 12:00 ET

  • Tianjin Chase Sun Pharmaceutical: 2024 First Quarter Report

    Apr 25, 2024 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jan 2, 2025

    Buy

    • Strong Buy

      0.00%

    • Buy

      100.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Price
    % Chg

    No Data

    Investment Theme Innovative Drugs
    Innovative Drugs
    Intraday-1.98%
    Traditional Chinese Medicine Concept
    Traditional Chinese Medicine Concept
    Intraday-2.22%
    Virus Prevention
    Virus Prevention
    Intraday-2.43%